eli lilly retatrutide study just released impressive results for retatrutide, an investigational weight loss drug that targets three hormones—and may deliver more weight loss than current GLP-1s. See link below ⬇️ retatrutide clinical study Eli Lilly

Every order gives you the chance to enter our Transformation Challenge and win your share of 7,000 every 2 months: 4 Winners: 1,000 cash each 6 Runners up: 500 cash each Grand finale prize: 10,000 cash Your order includes an exclusive I AM IN poster, perfect for capturing your before photo and marking the start of your New You journey

Two things that we know of as of right now

These standards were subjected to the same sample preparation protocol mentioned earlier, followed by the LC-MS analysis

Fu J, Nchambi KM, Wu H, Luo X, An X, Liu D

What Makes It Special: Tirzepatide mimics both GLP-1 and GIP hormones, which seems to create a more powerful effect on both appetite suppression and blood sugar control

10.1152/ajpregu.00588.2012 72 NaslundE.BarkelingB.KingN.GutniakM.BlundellJ